Published 1986 | Version v1
Book

Astatine-211: a powerful α-emitter for potential appplication in metabolic and contact therapy

  • 1. Technische Univ., Dresden (German Democratic Republic). Sektion Chemie
  • 2. Medizinische Akademie, Dresden (German Democratic Republic). Nuklearmedizinische Klinik

Description

Intensive research work in pharmacokinetics and the availability of highly pure α-emitters and Auger-electron-emitters like H-3, I-125, Bi-201, At-211, Ga-67 for different establishments gave the efforts in radionuclide therapy of tumors new stimulation. Thereby α-emitters are favourable distinguished by their high LET and pathways of several cell diameters both from Auger-electron-emitters and 'soft' β-emitters

Additional details

Publishing Information

Publisher
Editiones Roche.
Imprint Place
Basel (Switzerland)
Imprint Title
Radionuclides for therapy
Imprint Pagination
244 p.
Journal Page Range
p. 111-124.

Conference

Title
Use of radionuclides and vehicles for tumour therapy.
Dates
13-14 Jun 1986.
Place
Wuerenlingen/Villigen (Switzerland).